Remove 2022 Remove Consumption Remove Data Remove Sleep
article thumbnail

Veriheal’s 2023 Innovation In Cannabis Scholarship Winners

Veriheal

As we reflect on the success of the 2022 recipients, we are thrilled to introduce the exceptional winners of the 2023 scholarship. To alleviate this burden, we awarded $5,000 scholarships to five outstanding individuals in 2022. Veriheal recognizes the financial challenges students face in pursuing higher education.

article thumbnail

Answer of the Day for Aug 20, 2022

TheAnswerPage

Visual analog scale and numeric rating scale data, and sleep scores were collected on postoperative day 0, 1, 2, 7, 14, 42, and cumulative postoperative opioid use was evaluated. Apr 4, 2022. These results suggest that the local effects of topical CBD are not beneficial for providing additional pain relief after TKA.”

Topical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol

Veriheal

Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. It can also help with sleep, as many people like to use cannabis right before bed to feel immediate effects.

article thumbnail

Is Cannabis Good for Bipolar Disorder? New Study Shows Cannabis Has ‘Unique Benefits’

Veriheal

A team of researchers, who presented their study results during the Neuroscience 2022 conference , demonstrated that cannabis improves mental performance while reducing risky decision-making, a symptom commonly associated with bipolar disorder. By reducing dopaminergic transmissions in the brain, cannabis may help suppress bipolar symptoms.

article thumbnail

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The study was completed on March 22, 2022, and involved 1,061 participants, providing a 98% power rating on its results, which is statistically significant. The methods for both phases were the same.

Safety 52
article thumbnail

US Hemp Round Table: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The study was completed on March 22, 2022, and involved 1,061 participants, providing a 98% power rating on its results, which is statistically significant. The methods for both phases were the same.

Safety 52
article thumbnail

FDA Cites Five Companies for Illegally Selling Delta-8 THC and CBD Products

Cannabis Law Report

FDA states it has received 104 reports of adverse events in patients who consumed delta-8 THC products between December 1, 2020 and February 28, 2022. Food products for human or animal consumption that contain CBD or delta-8 THC are considered adulterated under the FFDCA. FDA states it has serious safety concerns with delta-8 THC.

THC 52